HINGHAM, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that LIBERTY was ...
HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced its participation in the inaugural ...
Over the past decades, the medical community has made fantastic leaps in innovation and medicine that have improved survival rates and quality of life for patients dealing with cancer, kidney disease, ...
BRAINTREE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT) today announced it has entered into an agreement with Emory University, which will allow the parties to evaluate and ...
Stereotaxis STXS recently secured FDA 510(k) clearance for GenesisX, its next-generation robotic system designed to make endovascular surgical robotics far more accessible. The approval marks a ...
Tiny robots might be the key to conducting more precise—and therefore more effective—endovascular surgery. Scientists in South Korea have developed a miniature magnetic robot capable of disrupting ...
(Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced today that Tampa General Hospital has become the first health system in Florida to adopt ...
International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advancements and Future Role of Endovascular Robotics LIBERTY ® Continues to Gain Commercial Traction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results